Corporate Social Responsibility

Gilead Sciences Corporate Social Responsibility

Videos from this campaign

Dilek, a mother of two from Germany who suffers from the rare chronic liver disease.
Happy Earth Day
Gilead representatives
TIME 100 2025
Mapping of HIV cases
centrifuge
image from event
"The Centrifuge Sessions"
"Ranked "best" at ESG by patient advocacy groups"
scientist working

Content from this campaign

Health & Healthcare

Gilead Sciences: Bringing PBC Into Focus Through Art of Patient Stories
“Living with primary biliary cholangitis (PBC) can be an isolating experience,” explains Dilek, a mother of two from Germany who suffers from the rare chronic liver disease.

Environment

Earth Day Focus for Gilead Sciences – Every Action Has an Impact
Creating a healthier world for all starts with taking care of the one we all share. As one of America's Greenest Companies, we're always working to ensure our medicines are delivered in ways that safeguard the planet.

Research, Reports & Publications

The 2024 Responsible Business and Impact Report Shares How Gilead Sciences Is Driving Change
At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share.

Awards, Ratings & Rankings

Tomas Cihlar, Gilead Sciences, Named to TIME’s List of 100 Most Influential People in the World for HIV Research
Congratulations to our very own Tomas Cihlar, Senior Vice President of Research, Virology, for being named to TIME's list of the 100 Most Influential People in the World.

Research, Reports & Publications

Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States
Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch AIDSVu – an online mapping tool that visualizes granular data

Events, Media & Communications

Fighting the World’s Most Devastating Diseases Is the Focus of This Installment of “The Centrifuge Sessions"
At Gilead, we set and achieve bold ambitions in our fight against the world’s most devastating diseases. In this installment of The Centrifuge Sessions, See Phan, Vice President, Oncology Clinical Development

Health & Healthcare

Biomedical HIV Prevention Summit in Atlanta Is the Focus To Drive Meaningful Action With Gilead Sciences
This year's Biomedical HIV Prevention Summit in Atlanta emphasized the importance of advancing prevention in the U.S. South, a region disproportionately impacted by HIV.

Health & Healthcare

The Centrifuge Sessions: Driving Innovation and Investment in Cancer Research
We’re focused on driving innovation in virology, oncology and immunology – and that includes investing in world-class science to change the way cancer is treated.

Health & Healthcare

Gilead Sciences: The Global Health Challenge of HIV and Hepatitis B Coinfections
In 2019, Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with hepatitis B (HBV) and with advanced HIV.

Awards, Ratings & Rankings

PatientView Ranks Gilead “Best” at ESG
At Gilead, putting people first is central to all we do. That’s why we’re proud to be recognized as a responsible company by patient advocacy groups representing more than 70 countries.
Gilead Sciences

More from Gilead Sciences

  1. Corporate Social Responsibility
    Gilead Sciences Corporate Social Responsibility

  2. Age Positively
    Those who experienced the early days of the HIV/AIDS epidemic remember the generation we lost and the enduring impact that has had on our community...

  3. Gilead 2015 CSR Report
    Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...